Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 03, 2015 3:44 AM ET

Biotechnology

Company Overview of Auspex Pharmaceuticals, Inc.

Company Overview

Auspex Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing novel medicines for the treatment of orphan diseases. The company’s product candidates are used to address medical needs primarily in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome, as well as other orphan indications. Its lead product candidate includes Austedo (SD-809), a final stage development product for the treatment of chorea associated with Huntington’s disease. The company’s other product candidates comprise SD-560, a deuterium-containing form of pirfenidone; SD-254, deuterium-containing form of venlafax...

3366 North Torrey Pines Court

Suite 225

San Diego, CA 92037

United States

Founded in 2001

35 Employees

Phone:

858-558-2400

Fax:

858-558-2401

Key Executives for Auspex Pharmaceuticals, Inc.

Chief Executive Officer, President and Director
Age: 45
Chief Financial Officer
Age: 52
Chief Operating Officer
Age: 50
Chief Medical Officer
Age: 54
Chief Development Officer and Director
Age: 60
Compensation as of Fiscal Year 2015.

Auspex Pharmaceuticals, Inc. Key Developments

Auspex Pharmaceuticals, Inc.(NasdaqGM:ASPX) dropped from Russell 2000 Index

Auspex Pharmaceuticals, Inc. will be removed from Russell 2000 Index.

Auspex Pharmaceuticals, Inc.(NasdaqGM:ASPX) dropped from Russell 3000 Index

Auspex Pharmaceuticals, Inc. will be removed from Russell 3000 Index.

Auspex Pharmaceuticals, Inc.(NasdaqGM:ASPX) dropped from NASDAQ Biotechnology Index

Auspex Pharmaceuticals, Inc. will be removed from NASDAQ Biotech Index.

Similar Private Companies By Industry

Company Name Region
Medicinal Genomics Corporation United States
Aixlie Pharmaceuticals, Inc. United States
MIICRO, Inc. United States
Clingenix, Inc. United States
Simbiosys Biowares Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
March 30, 2015
--
Merger/Acquisition
January 12, 2015
Imphar AG
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Auspex Pharmaceuticals, Inc., please visit www.auspexpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.